Cargando…
Metabolism-based targeting of MYC via MPC-SOD2 axis-mediated oxidation promotes cellular differentiation in group 3 medulloblastoma
Group 3 medulloblastoma (G3 MB) carries the worst prognosis of all MB subgroups. MYC oncoprotein is elevated in G3 MB tumors; however, the mechanisms that support MYC abundance remain unclear. Using metabolic and mechanistic profiling, we pinpoint a role for mitochondrial metabolism in regulating MY...
Autores principales: | Martell, Emma, Kuzmychova, Helgi, Kaul, Esha, Senthil, Harshal, Chowdhury, Subir Roy, Morrison, Ludivine Coudière, Fresnoza, Agnes, Zagozewski, Jamie, Venugopal, Chitra, Anderson, Chris M., Singh, Sheila K., Banerji, Versha, Werbowetski-Ogilvie, Tamra E., Sharif, Tanveer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154337/ https://www.ncbi.nlm.nih.gov/pubmed/37130865 http://dx.doi.org/10.1038/s41467-023-38049-9 |
Ejemplares similares
-
Compensatory cross-talk between autophagy and glycolysis regulates senescence and stemness in heterogeneous glioblastoma tumor subpopulations
por: Martell, Emma, et al.
Publicado: (2023) -
An OTX2-PAX3 signaling axis regulates Group 3 medulloblastoma cell fate
por: Zagozewski, Jamie, et al.
Publicado: (2020) -
Cross-species analysis of SHH medulloblastoma models reveals significant inhibitory effects of trametinib on tumor progression
por: Borlase, Stephanie, et al.
Publicado: (2023) -
OTX2 exhibits cell-context-dependent effects on cellular and molecular properties of human embryonic neural precursors and medulloblastoma cells
por: Kaur, Ravinder, et al.
Publicado: (2015) -
Characterization of a novel OTX2‐driven stem cell program in Group 3 and Group 4 medulloblastoma
por: Stromecki, Margaret, et al.
Publicado: (2018)